Warner Bros. Discovery
Utility Patents
Last updated:
List of all Warner Bros. Discovery patents 65 in total
| Status | Patent |
|---|---|
Grant | Utility: Identification of selected spectrum antibiotics Filling date: 8 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Heterocyclic compound as CSF-1R inhibitor and use thereof Filling date: 8 Sep 2025 Issue date: 12 Jul 2022 |
Grant | Utility: Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors Filling date: 8 Sep 2025 Issue date: 5 Jul 2022 |
Grant | Utility: Crystal and salt of 4-(naphthalen-1-yl)-4H-1,2,4-triazole compound and preparation method therefor Filling date: 8 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Asset search and discovery system using graph data structures Filling date: 8 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: Benzopyrazole compound used as RHO kinase inhibitor Filling date: 8 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: Crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound and preparation process therefor Filling date: 8 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same Filling date: 8 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Tricyclic furan-substituted piperidinedione compound Filling date: 8 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Prostacyclin receptor agonist Filling date: 8 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Salt and crystal form of modified andrographolide compound and preparation method thereof Filling date: 8 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Biomarkers of autism spectrum disorder Filling date: 8 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Compound as GLS1 inhibitor Filling date: 8 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Protein kinase inhibitors Filling date: 8 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Methods and systems for searching and indexing virtual environments Filling date: 8 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Substituted 1,3,4-thiadiazoles as GLS1 inhibitors Filling date: 8 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Quinolino-pyrrolidin-2-one derivative and application thereof Filling date: 8 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof Filling date: 8 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Substituted ureas and methods of making and using same Filling date: 8 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Crystal form and salt form of pyridone compound and preparation method therefor Filling date: 8 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: S1P1 agonist and application thereof Filling date: 8 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: Peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response Filling date: 8 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Biphenyl compound as CCR2/CCR5 receptor antagonist Filling date: 8 Sep 2025 Issue date: 26 Oct 2021 |
Grant | Utility: CXCR2 antagonist Filling date: 8 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: [1,2,4]triazolo[1,5-c]pyrimidine derivative as A.sub.2A receptor inhibitor Filling date: 8 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Combination therapies with disulfiram Filling date: 8 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Quinazoline compound for EGFR inhibition Filling date: 8 Sep 2025 Issue date: 22 Jun 2021 |
Grant | Utility: Combination therapies with disulfiram Filling date: 8 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Crystal form of URAT1 inhibitor, and preparation method therefor Filling date: 8 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: Alpha-cinnamide compounds and compositions as HDAC8 inhibitors Filling date: 8 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Filling date: 8 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors Filling date: 8 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Spiro compound and use thereof Filling date: 8 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof Filling date: 8 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors Filling date: 8 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors Filling date: 8 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors Filling date: 8 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: Methods and systems for determining the biological age of samples Filling date: 8 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: 2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors Filling date: 8 Sep 2025 Issue date: 29 Dec 2020 |
Grant | Utility: Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors Filling date: 8 Sep 2025 Issue date: 22 Dec 2020 |
Grant | Utility: Anti-HCMV virus compound Filling date: 8 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Filling date: 8 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same Filling date: 8 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Filling date: 8 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Filling date: 8 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: [6,6] fused bicyclic HDAC8 inhibitors Filling date: 8 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Filling date: 8 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Indole derivative used as CRTH2 inhibitor Filling date: 8 Sep 2025 Issue date: 13 Oct 2020 |
Grant | Utility: Modified compound of andrographolide Filling date: 8 Sep 2025 Issue date: 21 Jul 2020 |
Showing 1 to 50 of 65 patents.